AIIMS chief Dr Randeep Guleria has said that making Covid-19 vaccine available for children will be a milestone achievement and pave the way for reopening of schools and resumption of outdoor activities for them.
He said the data of phase two and three trial of Bharat Biotech's Covaxin on two to 18 years age group is expected by September.
He said the vaccine can be available for children in India around that time following approval from the drug regulator.
Dr Guleria told PTI that if the Pfizer vaccine gets approval before that, then it can also be an option for children.
According to a senior government official, pharmaceutical major Zydus Cadila is also likely to soon apply to the Drugs Controller General of India for emergency use authorisation for its Covid-19 vaccine ZyCoV-D, which it claims can be given to both adults and children.